Calprotectin Is a Useful Tool in Distinguishing Coexisting Irritable Bowel-Like Symptoms from That of Occult Inflammation among Inflammatory Bowel Disease Patients in Remission by Lars-Petter Jelsness-Jørgensen, Tomm Bernklev, Bjørn Moum

Get full text

The Use of Complementary and Alternative Medicine among Patients with Inflammatory Bowel Disease Is Associated with Reduced Health-Related Quality of Life by Randi Opheim, Marte Lie Høivik, Tomm Bernklev, Lars-Petter Jelsness-Jørgensen, Bjørn Moum

Get full text

Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis by Gert Huppertz-Hauss, Eline Aas, Marte Lie Høivik, Ebbe Langholz, Selwyn Odes, Milada Småstuen, Reinhold Stockbrugger, Geir Hoff, Bjørn Moum, Tomm Bernklev

Get full text

Validity, Reliability, and Responsiveness of the Brief Pain Inventory in Inflammatory Bowel Disease by Lars-Petter Jelsness-Jørgensen, Bjørn Moum, Tore Grimstad, Jørgen Jahnsen, Randi Opheim, Ingrid Prytz Berset, Øistein Hovde, Roald Torp, Svein Oskar Frigstad, Gert Huppertz-Hauss, Tomm Bernklev

Get full text

Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study by Tomm Bernklev, Pasquale Klepp, Stephan Brackmann, Milada Cvancarova, Marte Lie Hoivik, Øistein Hovde, Magne Henriksen, Gert Huppertz-Hauss, Ole Hoie, Iril Kempski-Monstad, Inger Camilla Solberg, Njaal Stray, Jorgen Jahnsen, Bjorn Moum

Get full text